SI2254570T1 - Kombinacija, obsegajoča paklitaksel, za zdravljenje raka na jajčnikih - Google Patents

Kombinacija, obsegajoča paklitaksel, za zdravljenje raka na jajčnikih

Info

Publication number
SI2254570T1
SI2254570T1 SI200930849T SI200930849T SI2254570T1 SI 2254570 T1 SI2254570 T1 SI 2254570T1 SI 200930849 T SI200930849 T SI 200930849T SI 200930849 T SI200930849 T SI 200930849T SI 2254570 T1 SI2254570 T1 SI 2254570T1
Authority
SI
Slovenia
Prior art keywords
paclitaxel
combination
ovarian cancer
treating ovarian
treating
Prior art date
Application number
SI200930849T
Other languages
English (en)
Inventor
Martine Clozel
Urs Regenass
Original Assignee
Actelion Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40670930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2254570(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd. filed Critical Actelion Pharmaceuticals Ltd.
Publication of SI2254570T1 publication Critical patent/SI2254570T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
SI200930849T 2008-02-20 2009-02-19 Kombinacija, obsegajoča paklitaksel, za zdravljenje raka na jajčnikih SI2254570T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2008050607 2008-02-20
EP09712334.3A EP2254570B1 (en) 2008-02-20 2009-02-19 Combination comprising paclitaxel for treating ovarian cancer
PCT/IB2009/050677 WO2009104149A1 (en) 2008-02-20 2009-02-19 Combination comprising paclitaxel for treating ovarian cancer

Publications (1)

Publication Number Publication Date
SI2254570T1 true SI2254570T1 (sl) 2014-03-31

Family

ID=40670930

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930849T SI2254570T1 (sl) 2008-02-20 2009-02-19 Kombinacija, obsegajoča paklitaksel, za zdravljenje raka na jajčnikih

Country Status (19)

Country Link
US (2) US8541433B2 (sl)
EP (1) EP2254570B1 (sl)
JP (1) JP5514123B2 (sl)
KR (1) KR20100132489A (sl)
CN (1) CN101939001B (sl)
AR (1) AR070456A1 (sl)
AU (1) AU2009215329B2 (sl)
CA (1) CA2714608A1 (sl)
CY (1) CY1115071T1 (sl)
DK (1) DK2254570T3 (sl)
ES (1) ES2446303T3 (sl)
HR (1) HRP20140215T1 (sl)
MX (1) MX2010008994A (sl)
PL (1) PL2254570T3 (sl)
PT (1) PT2254570E (sl)
RU (1) RU2494736C2 (sl)
SI (1) SI2254570T1 (sl)
TW (1) TWI441639B (sl)
WO (1) WO2009104149A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY151003A (en) 2005-09-12 2014-03-31 Actelion Pharmaceuticals Ltd Stable pharmaceutical composition comprising a pyrimidine-sulfamide
MX2010001837A (es) 2007-08-17 2010-03-10 Actelion Pharmaceuticals Ltd Derivados de 4-pirimidinasulfamida.
RU2494736C2 (ru) * 2008-02-20 2013-10-10 Актелион Фармасьютиклз Лтд Комбинация, включающая паклитаксел, для лечения рака яичников
NZ591601A (en) 2008-08-13 2012-12-21 Actelion Pharmaceuticals Ltd Therapeutic compositions containing macitentan and a prostacyclin receptor agonist
EP2464218B1 (en) 2009-08-10 2015-05-27 Board of Regents, The University of Texas System Treatment of brain metastases with inhibitors of endothelin receptors in combination with a cytotoxic chemotherapy agent
US20130310407A1 (en) * 2011-02-04 2013-11-21 Actelion Pharmaceuticals Ltd. Combinations comprising macitentan for the treatment of glioblastoma multiforme
CN103819411A (zh) * 2014-03-14 2014-05-28 成都克莱蒙医药科技有限公司 一种马西替坦中间体新的制备方法
CN106659765B (zh) 2014-04-04 2021-08-13 德玛医药 二脱水半乳糖醇及其类似物或衍生物用于治疗非小细胞肺癌和卵巢癌的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
IL155805A0 (en) * 2000-12-18 2003-12-23 Actelion Pharmaceuticals Ltd Novel sulfamides and their use as endothelin receptor antagonists
US20040138121A1 (en) * 2002-10-24 2004-07-15 Anil Gulati Method and composition for preventing and treating solid tumors
US20040121971A1 (en) 2002-12-20 2004-06-24 Gang Chen Therapeutic use of tumor necrosis factor-alpha mutein
GB0425854D0 (en) 2004-11-25 2004-12-29 Astrazeneca Ab Therapeutic treatment
MY151003A (en) 2005-09-12 2014-03-31 Actelion Pharmaceuticals Ltd Stable pharmaceutical composition comprising a pyrimidine-sulfamide
AR062501A1 (es) * 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
RU2494736C2 (ru) * 2008-02-20 2013-10-10 Актелион Фармасьютиклз Лтд Комбинация, включающая паклитаксел, для лечения рака яичников
KR20100005486A (ko) * 2008-07-07 2010-01-15 페어차일드코리아반도체 주식회사 스위치 제어 장치 및 이를 포함하는 컨버터

Also Published As

Publication number Publication date
CA2714608A1 (en) 2009-08-27
PL2254570T3 (pl) 2014-05-30
CY1115071T1 (el) 2016-12-14
US8541433B2 (en) 2013-09-24
AR070456A1 (es) 2010-04-07
EP2254570B1 (en) 2013-12-18
KR20100132489A (ko) 2010-12-17
TWI441639B (zh) 2014-06-21
AU2009215329A1 (en) 2009-08-27
TW200940062A (en) 2009-10-01
US20100311774A1 (en) 2010-12-09
JP2011512399A (ja) 2011-04-21
HRP20140215T1 (hr) 2014-04-11
RU2010138650A (ru) 2012-03-27
PT2254570E (pt) 2014-02-17
ES2446303T3 (es) 2014-03-07
AU2009215329B2 (en) 2014-08-21
CN101939001A (zh) 2011-01-05
DK2254570T3 (da) 2014-02-03
CN101939001B (zh) 2012-06-20
RU2494736C2 (ru) 2013-10-10
US20130317048A1 (en) 2013-11-28
EP2254570A1 (en) 2010-12-01
MX2010008994A (es) 2010-09-07
JP5514123B2 (ja) 2014-06-04
WO2009104149A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
HK1200363A1 (en) Compounds useful for treating cancer
EP2310006A4 (en) TREATMENT OF CANCER
HK1131577A1 (en) Compositions for treating cancer
IL209895A0 (en) Compounds for treating beta-amyloidoses
LT2303021T (lt) Junginiai, skirti vėžio gydymui
IL213398A0 (en) Compounds for treating cancer
EP2424516A4 (en) PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER
ZA201003123B (en) Thiazol derivavtives for treating cancer
PL2254570T3 (pl) Połączenie zawierające paklitaksel do leczenia raka jajnika
ZA201203449B (en) Sulfoxide derivatives for treating tumors
EP2144888A4 (en) METHODS OF TREATING CANCER
GB0804496D0 (en) Treating cancer
EP2210099A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
RS55074B1 (sr) Lapatinib za lečenje kancera
EP2068911A4 (en) METHOD FOR THE TREATMENT OF CANCER
EP2473506A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2281575A4 (en) ANTIBODIES FOR THE TREATMENT OF CANCER
GB0707556D0 (en) Treatment for cancer
EP2183234A4 (en) PROCESS FOR CONVERTING 9-DIHYDRO-13-ACETYLBACCATIN III IN DOCETAXEL OR PACLITAXEL
EP2307573A4 (en) METHODS FOR SCREENING COMPOUNDS FOR TREATING CANCER
GB0809046D0 (en) Cancer treatment
EP2319873A4 (en) DEXTRAN TO TREAT LUNG CANCER
GB0914322D0 (en) Compounds for treating cancer
GB0808116D0 (en) bioarker for pancreatic cancer
GB0619271D0 (en) Treating cancer